Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanbin Li

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Ageing Research Reviews|June 30, 2025
Targeting autophagy in doxorubicin-induced cardiotoxicity: A comprehensive review of scientific landscapes and therapeutic innovationsShiqi Wang, Lu Wang, Hongxin Cheng, et al.
Antimicrobial Agents and Chemotherapy|July 31, 2019
Long-Term Effects on QT Prolongation of Pretomanid Alone and in Combinations in Patients with TuberculosisHanbin Li, David H Salinger, Daniel Everitt, et al.
Signal Transduction and Targeted Therapy|November 27, 2025
Pulsed electromagnetic fields inhibit atherosclerosis by regulating pyroptosis through membrane tension-mediated mechanosensitive channelsHongxin Cheng, Qing Zhang, Wen Zhong, et al.
Archives of Gerontology and Geriatrics|June 3, 2026
Accelerometer-derived movement profiles incorporating volume, intensity, and transition dynamics: associations with chronic disease and mortality in older adultsWen Zhong, Lu Wang, Hanbin Li, et al.
Journal of Clinical Medicine|July 12, 2025
Hemoglobin-to-Red Cell Distribution Width Ratio Was Associated with Cardiovascular Diseases and DeathMengyi Li, Hanbin Li, Wen Zhong, et al.
Cancer Chemotherapy and Pharmacology|November 24, 2018
Population pharmacokinetic and covariate analyses of intravenous trastuzumab (Herceptin<sup>®</sup>), a HER2-targeted monoclonal antibody, in patients with a variety of solid tumorsAngelica L Quartino, Hanbin Li, Whitney P Kirschbrown, et al.
JACC. Basic to Translational Science|September 5, 2022
A Phase 1 Dose-Escalation Study of the Cardiac Myosin Inhibitor Aficamten in Healthy ParticipantsFady I Malik, Laura A Robertson, Danielle R Armas, et al.
Clinical Pharmacokinetics|January 10, 2017
Population Pharmacokinetic Analysis of Daclatasvir in Subjects with Chronic Hepatitis C Virus InfectionPhyllis Chan, Hanbin Li, Li Zhu, et al.
Clinical Medicine (London, England)|January 25, 2013
Glycated albumin is a potential diagnostic tool for diabetes mellitusChun Yang, Hanbin Li, Zhihai Wang, et al.
Cancer Chemotherapy and Pharmacology|August 15, 2014
Population pharmacokinetic and covariate analysis of pertuzumab, a HER2-targeted monoclonal antibody, and evaluation of a fixed, non-weight-based dose in patients with a variety of solid tumorsAmit Garg, Angelica Quartino, Jing Li, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Ageing Research Reviews|June 30, 2025
Targeting autophagy in doxorubicin-induced cardiotoxicity: A comprehensive review of scientific landscapes and therapeutic innovationsShiqi Wang, Lu Wang, Hongxin Cheng, et al.
Antimicrobial Agents and Chemotherapy|July 31, 2019
Long-Term Effects on QT Prolongation of Pretomanid Alone and in Combinations in Patients with TuberculosisHanbin Li, David H Salinger, Daniel Everitt, et al.
Signal Transduction and Targeted Therapy|November 27, 2025
Pulsed electromagnetic fields inhibit atherosclerosis by regulating pyroptosis through membrane tension-mediated mechanosensitive channelsHongxin Cheng, Qing Zhang, Wen Zhong, et al.
Archives of Gerontology and Geriatrics|June 3, 2026
Accelerometer-derived movement profiles incorporating volume, intensity, and transition dynamics: associations with chronic disease and mortality in older adultsWen Zhong, Lu Wang, Hanbin Li, et al.
Journal of Clinical Medicine|July 12, 2025
Hemoglobin-to-Red Cell Distribution Width Ratio Was Associated with Cardiovascular Diseases and DeathMengyi Li, Hanbin Li, Wen Zhong, et al.
Cancer Chemotherapy and Pharmacology|November 24, 2018
Population pharmacokinetic and covariate analyses of intravenous trastuzumab (Herceptin<sup>®</sup>), a HER2-targeted monoclonal antibody, in patients with a variety of solid tumorsAngelica L Quartino, Hanbin Li, Whitney P Kirschbrown, et al.
JACC. Basic to Translational Science|September 5, 2022
A Phase 1 Dose-Escalation Study of the Cardiac Myosin Inhibitor Aficamten in Healthy ParticipantsFady I Malik, Laura A Robertson, Danielle R Armas, et al.
Clinical Pharmacokinetics|January 10, 2017
Population Pharmacokinetic Analysis of Daclatasvir in Subjects with Chronic Hepatitis C Virus InfectionPhyllis Chan, Hanbin Li, Li Zhu, et al.
Clinical Medicine (London, England)|January 25, 2013
Glycated albumin is a potential diagnostic tool for diabetes mellitusChun Yang, Hanbin Li, Zhihai Wang, et al.
Cancer Chemotherapy and Pharmacology|August 15, 2014
Population pharmacokinetic and covariate analysis of pertuzumab, a HER2-targeted monoclonal antibody, and evaluation of a fixed, non-weight-based dose in patients with a variety of solid tumorsAmit Garg, Angelica Quartino, Jing Li, et al.
Pageof 4